We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$266M
AUM Growth
-$43.4M
(-14%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-16.65%
Top 10 Holdings %
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22
Avg Time Held
4.8
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
3.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$4.06M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$2.27M |
| 3 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
+$1.93M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$1.56M |
| 5 |
Axon Enterprise
AXON
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RH
RH
|
+$13M |
| 2 |
MacroGenics
MGNX
|
+$6.84M |
| 3 |
Alibaba
BABA
|
+$3.42M |
| 4 |
SANGAMO THERAPEUTICS INC
SGMO
|
+$3.21M |
| 5 |
HCA Healthcare
HCA
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.9% |
| 2 | Communication Services | 19.6% |
| 3 | Energy | 16.27% |
| 4 | Industrials | 12.61% |
| 5 | Technology | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.98T
| $8.75M | 3.29% |
317,020
-1,680
| -0.5% | -$45.7K |
2013 Q2
6 quarters
|
|
|
AGTC
2
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $7.86M | 2.96% |
373,882
+94,579
| +34% | +$1.93M |
2014 Q2
2 quarters
|
|
3
Union Pacific
UNP
$168B
| $7.43M | 2.8% |
62,370
-400
| -0.6% | -$45.9K |
2013 Q2
6 quarters
|
|
4
Enterprise Products Partners
EPD
$77.8B
| $7.03M | 2.65% |
194,510
-2,570
| -1% | -$95K |
2013 Q2
6 quarters
|
|
5
McKesson
MCK
$112B
| $6.96M | 2.62% |
33,550
-235
| -0.7% | -$47.7K |
2013 Q2
6 quarters
|
|
6
Blackstone
BX
$82.6B
| $6.25M | 2.35% |
188,388
-738
| -0.4% | -$23.1K |
2013 Q2
6 quarters
|
|
7
RTX Corp
RTX
$247B
| $6.25M | 2.35% |
86,362
-1,081
| -1% | -$73.7K |
2013 Q2
6 quarters
|
|
|
TFCFA
8
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $5.86M | 2.21% |
152,480
-950
| -0.6% | -$33.6K |
2013 Q3
5 quarters
|
|
9
Pfizer
PFE
$162B
| $5.69M | 2.14% |
192,401
-654
| -0.3% | -$18.8K |
2013 Q2
6 quarters
|
|
|
DTV
10
DELISTED
DIRECTV COM STK (DE)
DTV
| $5.59M | 2.11% |
64,485
+600
| +0.9% | +$51.6K |
2013 Q2
6 quarters
|
|
11
Madison Square Garden
MSGS
$9.73B
| $5.56M | 2.09% |
103,620
+657
| +0.6% | +$33.1K |
2014 Q1
3 quarters
|
|
12
Liberty Global Class C
LBTYK
$2.87B
| $5.56M | 2.09% |
142,293
-612
| -0.4% | -$22.3K |
2013 Q2
6 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$4.27T
| $5.42M | 2.04% |
204,981
+421
| +0.2% | +$11.3K |
2013 Q2
6 quarters
|
|
14
Danaher
DHR
$157B
| $4.97M | 1.87% |
86,241
-327
| -0.4% | -$17.7K |
2013 Q2
6 quarters
|
|
15
LyondellBasell Industries
LYB
$19.4B
| $4.86M | 1.83% |
61,225
-475
| -0.8% | -$41.2K |
2013 Q2
6 quarters
|
|
16
3M
MMM
$83.9B
| $4.75M | 1.79% |
34,612
-132
| -0.4% | -$16.9K |
2013 Q2
6 quarters
|
|
17
Canadian National Railway
CNI
$71.8B
| $4.66M | 1.76% |
67,680
-410
| -0.6% | -$28.1K |
2013 Q2
6 quarters
|
|
18
Plains All American Pipeline
PAA
$17.6B
| $4.65M | 1.75% |
90,584
-1,188
| -1% | -$63.1K |
2013 Q2
6 quarters
|
|
19
UnitedHealth
UNH
$339B
| $4.51M | 1.7% |
44,631
-325
| -0.7% | -$30.8K |
2014 Q3
1 quarter
|
|
20
SiriusXM
SIRI
$8.96B
| $4.47M | 1.68% |
127,729
-1,088
| -0.8% | -$37.5K |
2014 Q1
3 quarters
|
|
|
21
Qualcomm
QCOM
$189B
| $4.36M | 1.64% |
58,667
+55,425
| +1,710% | +$4.06M |
2013 Q3
5 quarters
|
|
22
Allstate
ALL
$59.8B
| $4.34M | 1.63% |
61,720
| – | – |
2014 Q1
3 quarters
|
|
23
Eaton
ETN
$166B
| $4.24M | 1.6% |
62,425
-220
| -0.4% | -$14.5K |
2013 Q2
6 quarters
|
|
24
DELISTED
Paramount Global Class B
PARA
| $4.17M | 1.57% |
75,442
-430
| -0.6% | -$22.9K |
2013 Q2
6 quarters
|
|
25
KKR & Co
KKR
$78.2B
| $4.07M | 1.53% |
175,175
-1,140
| -0.6% | -$25K |
2014 Q2
2 quarters
|
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.
Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.
- Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
- Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
- Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
- Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
- Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
- Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
- Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.
Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.